Navigation Links
Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th
Date:5/2/2011

NEW YORK, May 2, 2011 /PRNewswire/ -- Lpath, Inc. (OTCBB: LPTN), the category leader in bioactive-lipid-targeted therapeutics, today announced that Scott Pancoast, Lpath President and CEO, will present at RetailInvestorConferences.com.DATE:

May 5th, 2011TIME:

3:00 PM EDTLINK:

www.retailinvestorconferences.com>Click the red "register/ watch event now" button.This will be a live, interactive online event where investors are invited to ask the company questions in real-time both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About LpathSan Diego-based Lpath, a therapeutic antibody company, is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids for treating a wide range of human disease. Lpath's ImmuneY2(TM) drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company has developed three drug candidates, two of which -- ASONEP(TM) for cancer and iSONEP(TM) for wet AMD -- have completed Phase 1 clinical trials. Lpath entered into an agreement with Pfizer in 2010 that provides Pfizer an exclusive option for a worldwide license to develop and commercialize iSONEP. For more information, visit www.Lpath.com.

About RetailInvestorConferences.com:RetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire and MUNCmedia, is the first monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.

Forward-Looking Statements The Company cautions you that the statements included in this press release that are not a description of historical facts are forward-looking statements. These include statements regarding: the eventual commercial viability of the Company's drug programs; the eventual revenues that the Company would attain if the drug eventually gets approved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in the Company's business, including, without limitation: the results of any future clinical trials for iSONEP may not be favorable and the Company may never receive regulatory approval for iSONEP; and the Company may not be able to secure the funds necessary to support its clinical trial and product development plans. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q filed with the SEC. Such documents may be read free of charge on the SEC's web site at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.


'/>"/>

SOURCE Lpath, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Technest Holdings, Inc. to Acquire AccelPath, LLC; Issue Contingent Value Rights to Common Stockholders; and Issue Shares of Its Series E 5% Convertible Preferred Stock
2. Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th
3. Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event
4. Volcano Corporation Presentation at JMP Securities Conference to be Webcast
5. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
6. Henry Schein to Present at Deutsche Bank 36th Annual Health Care Conference
7. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
8. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
9. Zimmer Holdings to Present at Deutsche Bank Securities, Inc. 36th Annual Health Care Conference
10. Inovio Pharmaceuticals to Present at Investor Conferences
11. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 2017 Systems Magnetic resonance imaging ... of the organs and tissues in the body with ... The technique does not use ionizing radiation either for ... growth of cancer. MRI is used for a variety ... and orthopedics. Hence, MRI helps in the diagnosis and ...
(Date:2/20/2017)... Feb. 20, 2017  Henry Schein, Inc. (Nasdaq: HSIC), ... products and services to office-based dental, animal ... it has entered into an agreement to ... leading U.S. distributor of anesthesia and surgical ... periodontists. SAS offers controlled and non-controlled pharmaceuticals, ...
(Date:2/20/2017)...  National Decision Support Company (NDSC) announces its ... Imaging platform within the full range of MEDITECH ... foundation for MEDITECH sites, through a directly supported ... Support Mechanism through the MEDITECH EHR. ... the integration of NDSC,s mechanism, which enables provider ...
Breaking Medicine Technology:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... Chuck E. ... Sensory Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, ... other special needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s ...
(Date:2/19/2017)... Carolina (PRWEB) , ... February 19, 2017 , ... The ... evening undergraduate nursing students, is being led by Amelia Joseph, Ph.D. Joseph was engaged ... initial operations of the nursing department in early 2016. After a nation-wide search, she ...
(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic ... MEDfx and the Delaware Health Information Network (DHIN) have partnered to improve connectivity ... state-wide health information exchange, DHIN stores and shares real-time health data for more ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... ... Park Cities Pet Sitter President, Joette White, has been featured on Episode ... The episode, which was posted this week, features a 30-minute interview of White by ... Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business of ...
Breaking Medicine News(10 mins):